What Happened?

A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. The positive sentiment swept across markets after it was announced the U.S. and Japan had reached a new trade deal. The agreement included a 15% tariff on Japanese goods imported into the U.S. and a commitment from Japan to invest $550 billion in the U.S. and open its markets to American cars and agricultural products. This development boosted investor confidence and contributed to a widespread rally, lifting stocks across many sectors. The Dow Jones Industrial Average and the S&P 500 both posted gains, creating a favorable environment that likely benefited individual stocks.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.

Among others, the following stocks were impacted:

• Hospital Chains company Acadia Healthcare (NASDAQ: ACHC) jumped 3.7%. Is now the time to buy Acadia Healthcare? Access our full analysis report here, it’s free.
• Dental Equipment & Technology company Henry Schein (NASDAQ: HSIC) jumped 3.5%. Is now the time to buy Henry Schein? Access our full analysis report here, it’s free.
• Senior Health, Home Health & Hospice company The Pennant Group (NASDAQ: PNTG) jumped 3.3%. Is now the time to buy The Pennant Group? Access our full analysis report here, it’s free.
• Digital Media & Content Platforms company Ziff Davis (NASDAQ: ZD) jumped 3.1%. Is now the time to buy Ziff Davis? Access our full analysis report here, it’s free.
• Project Management Software company Atlassian (NASDAQ: TEAM) jumped 3%. Is now the time to buy Atlassian? Access our full analysis report here, it’s free.

Zooming In On Acadia Healthcare (ACHC)

Acadia Healthcare’s shares are quite volatile and have had 16 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 5 days ago when the stock dropped 3.4% as several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively. Additionally, some pharmaceutical and biotech companies experienced sharp drops following unfavorable news; for instance, Sarepta Therapeutics plunged after a report indicated another patient death tied to its experimental gene therapy, and GSK's blood cancer drug dosage was voted against by the FDA advisory committee. Broader market sentiment, including concerns about rising costs and inadequate pricing for 2025 plans among health insurers, also contributed to the downward pressure on healthcare equities.

Acadia Healthcare is down 43.8% since the beginning of the year, and at $22.92 per share, it is trading 72% below its 52-week high of $81.93 from August 2024. Investors who bought $1,000 worth of Acadia Healthcare’s shares 5 years ago would now be looking at an investment worth $791.17.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.